Article Text
Research ethics
Ethical dilemmas: feeding back results to members of a longitudinal cohort study
Statistics from Altmetric.com
Does feedback of abnormal results affect validity during a longitudinal study?
A fundamental requirement of research is that no harm should come to the participants; however, being granted ethical approval for research does not imply that individuals will necessarily benefit from participation.
Certain ethical dilemmas become apparent only during the course of a longitudinal cohort study, such as the EarlyBird diabetes study in Plymouth, Devon.1 In this non-intervention study, the aim is to observe children for 12 years, monitoring for early signs of insulin resistance. A substantial volume of data is gathered every 6 months on the children and their parents, relating to lifestyle and indices of metabolic health. …
Read the full text or download the PDF:
Other content recommended for you
- Physical activity at the government-recommended level and obesity-related health outcomes: a longitudinal study (Early Bird 37)
- Fatness leads to inactivity, but inactivity does not lead to fatness: a longitudinal study in children (EarlyBird 45)
- Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies
- Cardiometabolic health in adolescence and its association with educational outcomes
- Understanding the rising incidence of type 2 diabetes in adolescence
- Awareness, experiences and perceptions regarding genetic testing and the return of genetic and genomics results in a hypothetical research context among patients in Uganda: a qualitative study
- Does birth weight predict childhood diet in the Avon longitudinal study of parents and children?
- The influence of the food environment on overweight and obesity in young children: a systematic review
- Haemoglobin and red blood cell reference intervals during infancy
- Takeaway meal consumption and risk markers for coronary heart disease, type 2 diabetes and obesity in children aged 9–10 years: a cross-sectional study